GLP-1 receptor agonists for people with type 2 diabetes and peripheral artery disease: reducing uncertainty in clinical practice
- DOI
- 10.1007/s12020-026-04847-6
- Published
- 2026-11-10
- Container
- Endocrine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12020-026-04847-6,
title = {GLP-1 receptor agonists for people with type 2 diabetes and peripheral artery disease: reducing uncertainty in clinical practice},
author = {Dario Giugliano and Paola Caruso and Miriam Longo and Lorenzo Scappaticcio and Giuseppe Bellastella and Maria Ida Maiorino and Katherine Esposito},
year = {2026},
journal = {Endocrine},
doi = {10.1007/s12020-026-04847-6},
url = {https://doi.org/10.1007/s12020-026-04847-6}
}RIS
TY - JOUR TI - GLP-1 receptor agonists for people with type 2 diabetes and peripheral artery disease: reducing uncertainty in clinical practice AU - Dario Giugliano AU - Paola Caruso AU - Miriam Longo AU - Lorenzo Scappaticcio AU - Giuseppe Bellastella AU - Maria Ida Maiorino AU - Katherine Esposito PY - 2026 JO - Endocrine DO - 10.1007/s12020-026-04847-6 UR - https://doi.org/10.1007/s12020-026-04847-6 ER -
APA
Giugliano, D., Caruso, P., Longo, M., Scappaticcio, L., Bellastella, G., Maiorino, M. I., & Esposito, K. (2026). GLP-1 receptor agonists for people with type 2 diabetes and peripheral artery disease: reducing uncertainty in clinical practice. Endocrine. https://doi.org/10.1007/s12020-026-04847-6
Source records
- crossref · retrieved 2026-11-11T01:25:02.367Z